Potential therapeutic effects of oleuropein aglycone in Alzheimer's disease

Current Pharmaceutical Biotechnology

Volumn 17, Issue 11, 2016, Pages 994-1001

  Martorell, Miquel ^a   Forman, Katherine ^a   Castro, Natalia ^a   Capó, Xavier ^b   Tejada, Silvia ^c   Sureda, Antoni ^b,d  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^c HOSPITAL SON LLÀTZER   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

Alzheimer s disease; Neurodegenerative disease; Olea europaea; Oleuropein aglycone; Oxidative stress; Phenolic compounds

Indexed keywords

AGLYCONE; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ANTIOXIDANT; EXTRA VIRGIN OLIVE OIL; FLAVONOID; GLUCOSIDASE; MITOGEN ACTIVATED PROTEIN KINASE; OLEUROPEIN; POLYPHENOL; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SECOIRIDOID; TAU PROTEIN; AMYLOID PRECURSOR PROTEIN; IRIDOID; OLIVE OIL;

ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYLOIDOSIS; AUTOPHAGY; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DRUG BIOAVAILABILITY; HUMAN; LIPID PEROXIDATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN AGGREGATION; PROTEIN CARBONYLATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; TREATMENT OUTCOME;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIOXIDANTS; AUTOPHAGY; HUMANS; IRIDOIDS; OLIVE OIL; POLYPHENOLS; TREATMENT OUTCOME;

EID: 84989221391     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201017666160725120656     Document Type: Review

References (117)

1. Rigacci, S. Olive oil phenols as promising multi-targeting agents against Alzheimer's disease, Chapter 1. Natural compounds as therapeutic agents for amyloidogenic diseases, 2015, 863, 1-20.
2. Arimon, M.; Takeda, S.; Post, K.L.; Svirsky, S.; Hyman, B.T.; Berezovska, O. Oxidative stress and lipid peroxidation are upstream of amyloid pathology. Neurobiol. Dis., 2015.
3. Hardy, J.; Selkoe, D.J. Medicine-The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science, 2002, 297(5580), 353-356.
4. Martinez-Gonzalez, M.A.; Garcia-Lopez, M.; Bes-Rastrollo, M.; Toledo, E.; Martinez-Lapiscina, E.H.; Delgado-Rodriguez, M.; Vazquez, Z.; Benito, S.; Beunza, J.J. Mediterranean diet and the incidence of cardiovascular disease: A Spanish cohort. Nutr. Metab. Cardiovasc. Dis., 2011, 21(4), 237-244.
5. Sofi, F.; Abbate, R.; Gensini, G.F.; Casini, A. Accruing evidence on benefits of adherence to the Mediterranean diet on health an updated systematic review and meta-analysis. Am. J. Clin. Nutr., 2010, 92(5), 1189-1196.
6. Benetou, V.; Trichopoulou, A.; Orfanos, P.; Naska, A.; Lagiou, P.; Boffetta, P.; Trichopoulos, D. Conformity to traditional Mediterranean diet and cancer incidence: The Greek EPIC cohort. Br. J. Cancer, 2008, 99(1), 191-195.
7. Lopez-Miranda, J.; Perez-Jimenez, F.; Ros, E.; De Caterina, R.; Badimon, L.; Covas, M.I.; Escrich, E.; Ordovas, J.M.; Soriguer, F.; Abia, R.; Alarcon de la Lastra, C.; Battino, M.; Corella, D.; Chamorro-Quiros, J.; Delgado-Lista, J.; Giugliano, D.; Esposito, K.; Estruch, R.; Fernandez-Real, J.M.; Gaforio, J.J.; La Vecchia, C.; Lairon, D.; Lopez-Segura, F.; Mata, P.; Menendez, J.A.; Muriana, F.J.; Osada, J.; Panagiotakos, D.B.; Paniagua, J.A.; Perez-Martinez, P.; Perona, J.; Peinado, M.A.; Pineda-Priego, M.; Poulsen, H.E.; Quiles, J.L.; Ramirez-Tortosa, M.C.; Ruano, J.; Serra-Majem, L.; Sola, R.; Solanas, M.; Solfrizzi, V.; de la Torre-Fornell, R.; Trichopoulou, A.; Uceda, M.; Villalba-Montoro, J.M.; Villar-Ortiz, J.R.; Visioli, F.; Yiannakouris, N. Olive oil and health: Summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008. Nutr. Metab. Cardiovasc. Dis., 2010, 20(4), 284-294.
8. Menendez, J.A.; Joven, J.; Aragones, G.; Barrajon-Catalan, E.; Beltran-Debon, R.; Borras-Linares, I.; Camps, J.; Corominas-Faja, B.; Cufi, S.; Fernandez-Arroyo, S.; Garcia-Heredia, A.; Hernandez-Aguilera, A.; Herranz-Lopez, M.; Jimenez-Sanchez, C.; Lopez-Bonet, E.; Lozano-Sanchez, J.; Luciano-Mateo, F.; Martin-Castillo, B.; Martin-Paredero, V.; Perez-Sanchez, A.; Oliveras-Ferraros, C.; Riera-Borrull, M.; Rodriguez-Gallego, E.; Quirantes-Pine, R.; Rull, A.; Tomas-Menor, L.; Vazquez-Martin, A.; Alonso-Villaverde, C.; Micol, V.; Segura-Carretero, A. Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil. A new family of gerosuppressant agents. Cell Cycle, 2013, 12(4), 555-578.
9. Casamenti, F.; Grossi, C.; Rigacci, S.; Pantano, D.; Luccarini, I.; Stefani, M. Oleuropein aglycone: A possible drug against degenerative conditions: In vivo evidence of its effectiveness against Alzheimer's disease. J. Alzheimers Dis., 2015, 45(3), 679-688.
10. Rigacci, S.; Guidotti, V.; Bucciantini, M.; Nichino, D.; Relini, A.; Berti, A.; Stefani, M. A beta(1-42) Aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. Curr. Alzheimer Res., 2011, 8(8), 841-852.
11. Stefani, M.; Rigacci, S. Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation. Biofactors, 2014, 40(5), 482-493.
12. Abuznait, A.H.; Qosa, H.; Busnena, B.A.; El Sayed, K.A.; Kaddoumi, A. Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alz heimer's disease: In vitro and in vivo studies. ACS Chem. Neurosci., 2013, 4(6), 973-982.
13. Monti, M.C.; Margarucci, L.; Riccio, R.; Casapullo, A. Modulation of Tau protein fibrillization by oleocanthal. J. Nat. Prod., 2012, 75(9), 1584-1588.
14. Galiano, V.; Villalaín, J. Oleuropein aglycone in lipid bilayer membranes. A molecular dynamics study. Biochim. Biophys. Acta, 2015, 1848(11 Pt A), 2849-2858.
15. Lopez, S.; Bermudez, B.; Montserrat-de la Paz, S.; Jaramillo, S.; Varela, L.M.; Ortega-Gomez, A.; Abia, R.; Muriana, F.J.G. Membrane composition and dynamics: A target of bioactive virgin olive oil constituents. Biochim. Biophys. Acta, Rev. Biomembr., 2014, 1838(6), 1638-1656.
16. Bendini, A.; Cerretani, L.; Carrasco-Pancorbo, A.; Gomez-Caravaca, A.M.; Segura-Carretero, A.; Fernandez-Gutierrez, A.; Lercker, G. Phenolic molecules in virgin olive oils: A survey of their sensory properties, health effects, antioxidant activity and analytical methods. An overview of the last decade. Molecules, 2007, 12(8), 1679-1719.
17. Valls-Pedret, C.; Maria Lamuela-Raventos, R.; Medina-Remon, A.; Quintana, M.; Corella, D.; Pinto, X.; Angel Martinez-Gonzalez, M.; Estruch, R.; Ros, E. Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk. J. Alzheimers Dis., 2012, 29(4), 773-782.
18. Martinez-Lapiscina, E.H.; Clavero, P.; Toledo, E.; San Julian, B.; Sanchez-Tainta, A.; Corella, D.; Lamuela-Raventos, R.M.; Martinez, J.A.; Martinez-Gonzalez, M.A. Virgin olive oil supplementation and long-term cognition: The Predimed-Navarra randomized, trial. J. Nutr. Health & Aging, 2013, 17(6), 544-552.
19. Tangney, C.C.; Kwasny, M.J.; Li, H.; Wilson, R.S.; Evans, D.A.; Morris, M.C. Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population. Am. J. Clin. Nutr., 2011, 93(3), 601-607.
20. Vazquez-Martin, A.; Fernandez-Arroyo, S.; Cufi, S.; Oliveras-Ferraros, C.; Lozano-Sanchez, J.; Vellon, L.; Micol, V.; Joven, J.; Segura-Carretero, A.; Menendez, J.A. Phenolic secoiridoids in extra virgin olive oil impede fibrogenic and oncogenic epithelial-tomesenchymal transition: extra virgin olive oil as a source of novel antiaging phytochemicals. Rejuvenation Res., 2012, 15(1), 3-21.
21. Romani, A.; Mulinacci, N.; Pinelli, P.; Vincieri, F.F.; Cimato, A. Polyphenolic content in five Tuscany cultivars of Olea europaea L. J. Agric. Food Chem., 1999, 47(3), 964-967.
22. Franconi, F.; Coinu, R.; Carta, S.; Urgeghe, P.P.; Ieri, F.; Mulinacci, N.; Romani, A. Antioxidant effect of two virgin olive oils depends on the concentration and composition of minor polar compounds. J. Agric. Food Chem., 2006, 54(8), 3121-3125.
23. Brenes, M.; Garcia, A.; Garcia, P.; Rios, J.J.; Garrido, A. Phenolic compounds in Spanish olive oils. J. Agric. Food Chem., 1999, 47(9), 3535-3540.
24. Tripoli, E.; Giammanco, M.; Tabacchi, G.; Di Majo, D.; Giammanco, S.; La Guardia, M. The phenolic compounds of olive oil: Structure, biological activity and beneficial effects on human health. Nutr. Res. Rev., 2005, 18(1), 98-112.
25. Cicerale, S.; Conlan, X.A.; Sinclair, A.J.; Keast, R.S.J. Chemistry and health of olive oil phenolics. Crit. Rev. Food Sci. Nutr., 2009, 49(3), 218-236.
26. Luccarini, I.; Grossi, C.; Rigacci, S.; Coppi, E.; Pugliese, A.M.; Pantano, D.; la Marca, G.; Dami, T.E.; Berti, A.; Stefani, M.; Casamenti, F. Oleuropein aglycone protects against pyroglutamylated-3 amyloid-beta toxicity: biochemical, epigenetic and functional correlates. Neurobiol. Aging, 2015, 36(2), 648-663.
27. Luccarini, I.; Dami, T.E.; Grossi, C.; Rigacci, S.; Stefani, M.; Casamenti, F. Oleuropein aglycone counteracts a beta 42 toxicity in the rat brain. Neurosci. Lett., 2014, 558, 67-72.
28. Grossi, C.; Rigacci, S.; Ambrosini, S.; Dami, T.E.; Luccarini, I.; Traini, C.; Failli, P.; Berti, A.; Casamenti, F.; Stefani, M. The polyphenol oleuropein aglycone protects TgCRND8 mice against a beta plaque pathology. Plos One, 2013, 8(8).
29. Diomede, L.; Rigacci, S.; Romeo, M.; Stefani, M.; Salmona, M. Oleuropein aglycone protects transgenic C. elegans strains expressing a beta 42 by reducing plaque load and motor deficit. Plos One, 2013, 8(3).
30. Janahmadi, Z.; Nekooeian, A.A.; Moaref, A.R.; Emamghoreishi, M. Oleuropein offers cardioprotection in rats with acute myocardial infarction. Cardiovasc. Toxicol., 2015, 15(1), 61-68.
31. De Marino, S.; Festa, C.; Zollo, F.; Nini, A.; Antenucci, L.; Raimo, G.; Iorizzi, M. Antioxidant activity and chemical components as potential anticancer agents in the olive leaf (Olea europaea L. cv Leccino.) Decoction. Anti-Cancer Agents in Med. Chem., 2014, 14(10), 1376-1385.
32. Muscoli, C.; Lauro, F.; Dagostino, C.; Ilari, S.; Giancotti, L.A.; Gliozzi, M.; Costa, N.; Carresi, C.; Musolino, V.; Casale, F.; Ventrice, D.; Oliverio, M.; Palma, E.; Nistico, S.; Procopio, A.; Mollace, V. Olea europea-derived phenolic products attenuate antinociceptive morphine tolerancee: An innovative strategic approach to treat cancer pain. J. Biol. Regul. Homeost. Agents, 2014, 28(1), 105-116.
33. Barbaro, B.; Toietta, G.; Maggio, R.; Arciello, M.; Tarocchi, M.; Galli, A.; Balsano, C. Effects of the olive-derived polyphenol oleuropein on human health. Int. J. Mol. Sci., 2014, 15(10), 18508-18524.
34. Corominas-Faja, B.; Santangelo, E.; Cuyas, E.; Micol, V.; Joven, J.; Ariza, X.; Segura-Carretero, A.; Garcia, J.; Menendez, J.A. Computer-aided discovery of biological activity spectra for antiaging and anti-cancer olive oil oleuropeins. Aging-Us, 2014, 6(9), 731-741.
35. Daccache, A.; Lion, C.; Sibille, N.; Gerard, M.; Slomianny, C.; Lippens, G.; Cotelle, P. Oleuropein and derivatives from olives as Tau aggregation inhibitors. Neurochem. Int., 2011, 58(6), 700-707.
36. Vossel, K.A.; Zhang, K.; Brodbeck, J.; Daub, A.C.; Sharma, P.; Finkbeiner, S.; Cui, B.; Mucke, L. Tau reduction prevents Abetainduced defects in axonal transport. Science, 2010, 330(6001), 198.
37. Weingarten, M.D.; Lockwood, A.H.; Hwo, S.Y.; Kirschner, M.W. A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. USA, 1975, 72(5), 1858-1862.
38. Finkel, T.; Holbrook, N.J. Oxidants, oxidative stress and the biology of ageing. Nature, 2000, 408(6809), 239-247.
39. Swomley, A.M.; Butterfield, D.A. Oxidative stress in Alzheimer disease and mild cognitive impairment: Evidence from human data provided by redox proteomics. Arch. Toxicol., 2015, 89(10), 1669-1680.
40. Glabe, C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J. Mol. Neurosci., 2001, 17(2), 137-145.
41. Walsh, D.M.; Selkoe, D.J. Oligomers in the brain: The emerging role of soluble protein aggregates in neurodegeneration. Protein Pept. Lett., 2004, 11(3), 213-228.
42. Andreadis, A.; Brown, W.M.; Kosik, K.S. Structure and novel exons on the human-Tau gene. Biochem., 1992, 31(43), 10626-10633.
43. Glabe, C.C. Amyloid accumulation and pathogensis of Alzheimer's disease: Significance of monomeric, oligomeric and fibrillar Abeta. Subcell Biochem., 2005, 38, 167-177.
44. Hardy, J.A.; Higgins, G.A. Alzheimer's-disease-the amyloid cascade hypothesis. Science, 1992, 256(5054), 184-185.
45. Bergmans, B.A.; De Strooper, B. Gamma-secretases: from cell biology to therapeutic strategies. Lancet Neurol., 2010, 9(2), 215-226.
46. Chang, Y.-T.; Chang, W.-N.; Tsai, N.-W.; Huang, C.-C.; Kung, C.-T.; Su, Y.-J.; Lin, W.-C.; Cheng, B.-C.; Su, C.-M.; Chiang, Y.-F.; Lu, C.-H. The roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: A systematic review. Biomed Res. Int., 2014, 2014, 182303.
47. Rodrigues, R.; Petersen, R.B.; Perry, G. Parallels between major depressive disorder and Alzheimer's disease: Role of oxidative stress and genetic vulnerability. Cell Mol. Neurobiol., 2014, 34(7), 925-949.
48. Smith, M.A.; Rottkamp, C.A.; Nunomura, A.; Raina, A.K.; Perry, G. Oxidative stress in Alzheimer's disease. BBA-Mol. Basis Dis., 2000, 1502(1), 139-144.
49. Mangialasche, F.; Polidori, M.C.; Monastero, R.; Ercolani, S.; Camarda, C.; Cecchetti, R.; Mecocci, P. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res. Rev., 2009, 8(4), 285-305.
50. Reed, T.T.; Pierce, W.M., Jr.; Turner, D.M.; Markesbery, W.R.; Butterfield, D.A. Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule. J. Cell Mol. Med., 2009, 13(8B), 2019-2029.
51. Reed, T.T.; Pierce, W.M.; Markesbery, W.R.; Butterfield, D.A. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. Brain Res., 2009, 1274, 66-76.
52. Sultana, R.; Butterfield, D.A. Role of Oxidative Stress in the Progression of Alzheimer's Disease. J. Alzheimers Dis., 2010, 19(1), 341-353.
53. Sun, S.-Y. N-acetylcysteine, reactive oxygen species and beyond. Cancer Biol. Ther., 2010, 9(2), 109-110.
54. Subramanian, R.; Tam, J.; Aidasani, D.; Reid, D.L.; Skiles, G.L. Novel cytochrome P450 bioactivation of a terminal phenyl acetylene group: Formation of a one-carbon loss benzaldehyde and other oxidative products in the presence of n-acetyl cysteine or glutathione. Chem. Res. Toxicol., 2011, 24(5), 677-686.
55. Casado, A.; Lopez-Fernandez, M.E.; Casado, M.C.; de la Torre, R. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem. Res., 2008, 33(3), 450-458.
56. Olga Cristalli, D.; Arnal, N.; Ariel Marra, F.; de Alaniz, M.J.T.; Alberto Marra, C. Peripheral markers in neurodegenerative patients and their first-degree relatives. J. Neurol. Sci., 2012, 314(1-2), 48-56.
57. Bermejo, P.; GomezSerranillos, P.; Santos, J.; Pastor, E.; Gil, P.; MartinAragon, S. Determination of malonaldehyde in Alzheimer's disease: A comparative study of high-performance liquid chromatography and thiobarbituric acid test. Gerontology, 1997, 43(4), 218-222.
58. Aksenov, M.Y.; Aksenova, M.V.; Butterfield, D.A.; Geddes, J.W.; Markesbery, W.R. Protein oxidation in the brain in Alzheimer's disease. Neuroscience, 2001, 103(2), 373-383.
59. Bourdel-Marchasson, I.; Delmas-Beauvieux, M.C.; Peuchant, E.; Richard-Harston, S.; Decamps, A.; Reignier, B.; Emeriau, J.P.; Rainfray, M. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing, 2001, 30(3), 235-241.
60. Mecocci, P.; Polidori, M.C.; Cherubini, A.; Ingegni, T.; Mattioli, P.; Catani, M.; Rinaldi, P.; Cecchetti, R.; Stahl, W.; Senin, U.; Beal, M.F. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch. Neurol., 2002, 59(5), 794-798.
61. Aldred, S.; Bennett, S.; Mecocci, P. Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease. Clin. Biochem., 2010, 43(3), 267-271.
62. Korolainen, M.A.; Pirttila, T. Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease. Acta Neurol. Scand., 2009, 119(1), 32-38.
63. Vural, H.; Demirin, H.; Kara, Y.; Eren, I.; Delibas, N. Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. J. Trace Elem. Med. Biol., 2010, 24(3), 169-173.
64. Padurariu, M.; Ciobica, A.; Hritcu, L.; Stoica, B.; Bild, W.; Stefanescu, C. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci. Lett., 2010, 469(1), 6-10.
65. Puertas, M.C.; Martinez-Martos, J.M.; Cobo, M.P.; Carrera, M.P.; Mayas, D.; Ramirez-Exposito, J. Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia. Exp. Gerontol., 2012, 47(8), 625-630.
66. Bermejo, P.; Martin-Aragon, S.; Benedi, J.; Susin, C.; Felici, E.; Gil, P.; Ribera, J.M.; Villar, A.M. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment. Free Radic. Res., 2008, 42(2), 162-170.
67. Krstic, D.; Knuesel, I. Deciphering the mechanism underlying lateonset Alzheimer disease. Nat. Rev. Neurol., 2013, 9(1), 25-34.
68. Kanamaru, T.; Kamimura, N.; Yokota, T.; Iuchi, K.; Nishimaki, K.; Takami, S.; Akashiba, H.; Shitaka, Y.; Katsura, K.-I.; Kimura, K.; Ohta, S. Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease. Neurosci. Lett., 2015, 587, 126-131.
69. Butterfield, D.A.; Reed, T.; Perluigi, M.; De Marco, C.; Coccia, R.; Cini, C.; Sultana, R. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci. Lett., 2006, 397(3), 170-173.
70. Chavez-Gutierrez, L.; Bammens, L.; Benilova, I.; Vandersteen, A.; Benurwar, M.; Borgers, M.; Lismont, S.; Zhou, L.; Van Cleynenbreugel, S.; Esselmann, H.; Wiltfang, J.; Serneels, L.; Karran, E.; Gijsen, H.; Schymkowitz, J.; Rousseau, F.; Broersen, K.; De Strooper, B. The mechanism of gamma-Secretase dysfunction in familial Alzheimer disease. Embo J., 2012, 31(10), 2261-2274.
71. Pratico, D.; Uryu, K.; Leight, S.; Trojanowswki, J.Q.; Lee, V.M.Y. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci., 2001, 21(12), 4183-4187.
72. McLellan, M.E.; Kajdasz, S.T.; Hyman, B.T.; Bacskai, B.J. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. J. Neurosci., 2003, 23(6), 2212-2217.
73. Garcia-Alloza, M.; Dodwell, S.A.; Meyer-Luehmann, M.; Hyman, B.T.; Bacskai, B.J. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J. Neuropathol. Exp. Neurol., 2006, 65(11), 1082-1089.
74. Xie, H.; Hou, S.; Jiang, J.; Sekutowicz, M.; Kelly, J.; Bacskai, B.J. Rapid cell death is preceded by amyloid plaque-mediated oxidative stress. Proc. Natl. Acad. Sci. USA, 2013, 110(19), 7904-7909.
75. Harris, M.E.; Hensley, K.; Butterfield, D.A.; Leedle, R.A.; Carney, J.M. Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons. Exp. Neurol., 1995, 131(2), 193-202.
76. Butterfield, D.A. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic. Res., 2002, 36(12), 1307-1313.
77. Butterfield, D.A.; Griffin, S.; Munch, G.; Pasinetti, G.M. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J. Alzheimers Dis., 2002, 4(3), 193-201.
78. Atamna, H.; Boyle, K. Amyloid-beta peptide binds with heme to form a peroxidase: Relationship to the cytopathologies of Alzheimer's disease. Proc. Natl. Acad. Sci. USA, 2006, 103(9), 3381-3386.
79. Shen, L.; Chen, C.; Yang, A.; Chen, Y.; Liu, Q.; Ni, J. Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage. J. Proteomics, 2015, 123, 101-113.
80. Suzuki, Y.J.; Carini, M.; Butterfield, D.A. Protein carbonylation. Antioxid. Redox Signal., 2010, 12(3), 323-325.
81. Khan, T.K.; Alkon, D.L. An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin. Proc. Natl. Acad. Sci. USA, 2006, 103(35), 13203-13207.
82. Mudher, A.; Lovestone, S. Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci., 2002, 25(1), 22-26.
83. Cardoso, S.M.; Santana, I.; Swerdlow, R.H.; Oliveira, C.R. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J. Neurochem., 2004, 89(6), 1417-1426.
84. Giraldo, E.; Lloret, A.; Fuchsberger, T.; Viña, J. Aβ and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: Protective role of vitamin E. Redox Biol., 2014, 2, 873-877.
85. Chung, H.Y.; Sung, B.; Jung, K.J.; Zou, Y.; Yu, B.P. The molecular inflammatory process in aging. Antioxid. Redox Signal., 2006, 8(3-4), 572-581.
86. Kim, T.S.; Pae, C.U.; Yoon, S.J.; Jang, W.Y.; Lee, N.J.; Kim, J.J.; Lee, S.J.; Lee, C.; Paik, I.H.; Lee, C.U. Decreased plasma antioxidants in patients with Alzheimer's disease. Int. J. Geriatr. Psychiat., 2006, 21(4), 344-348.
87. Venkateshappa, C.; Harish, G.; Mahadevan, A.; Bharath, M.M.S.; Shankar, S.K. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: Implications for neurodegeneration in Alzheimer's Disease. Neurochem. Res., 2012, 37(8), 1601-1614.
88. Sano, M.; Ernesto, C.; Thomas, R.G.; Klauber, M.R.; Schafer, K.; Grundman, M.; Woodbury, P.; Growdon, J.; Cotman, D.W.; Pfeiffer, E.; Schneider, L.S.; Thal, L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N. Engl. J. Med., 1997, 336(17), 1216-1222.
89. Dysken, M.W.; Sano, M.; Asthana, S.; Vertrees, J.E.; Pallaki, M.; Llorente, M.; Love, S.; Schellenberg, G.D.; McCarten, J.R.; Malphurs, J.; Prieto, S.; Chen, P.; Loreck, D.J.; Trapp, G.; Bakshi, R.S.; Mintzer, J.E.; Heidebrink, J.L.; Vidal-Cardona, A.; Arroyo, L.M.; Cruz, A.R.; Zachariah, S.; Kowall, N.W.; Chopra, M.P.; Craft, S.; Thielke, S.; Turvey, C.L.; Woodman, C.; Monnell, K.A.; Gordon, K.; Tomaska, J.; Segal, Y.; Peduzzi, P.N.; Guarino, P.D. Effect of vitamin E and memantine on functional decline in Alzheimer disease the TEAM-AD VA cooperative randomized trial. JAMA, 2014, 311(1), 33-44.
90. Farina, N.; Isaac, M.G.E.K.N.; Clark, A.R.; Rusted, J.; Tabet, N. Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst. Rev., 2012, (11).
91. Lloret, A.; Badía, M.C.; Mora, N.J.; Pallardó, F.V.; Alonso, M.D.; Viña, J. Vitamin E paradox in Alzheimer's disease: It does not prevent loss of cognition and may even be detrimental. J. Alzheimers Dis., 2009, 17(1), 143-149.
92. Persson, T.; Popescu, B.O.; Cedazo-Minguez, A. Oxidative stress in Alzheimer's disease: Why did antioxidant therapy fail? Oxid. Med. Cell Longev., 2014, 2014, 427318.
93. Butterfield, D.A.; Swomley, A.M.; Sultana, R. Amyloid betapeptide (1-42)-induced oxidative stress in Alzheimer Disease: Importance in disease pathogenesis and progression. Antioxid. Redox Signal., 2013, 19(8), 823-835.
94. Gutierrez-Rosales, F.; Romero, M.P.; Casanovas, M.; Motilva, M.J.; Mínguez-Mosquera, M.I. Metabolites involved in oleuropein accumulation and degradation in fruits of Olea europaea L.: Hojiblanca and Arbequina varieties. J. Agric. Food Chem., 2010, 58(24), 12924-12933.
95. Alagna, F.; Mariotti, R.; Panara, F.; Caporali, S.; Urbani, S.; Veneziani, G.; Esposto, S.; Taticchi, A.; Rosati, A.; Rao, R.; Perrotta, G.; Servili, M.; Baldoni, L. Olive phenolic compounds: Metabolic and transcriptional profiling during fruit development. BMC Plant Biol., 2012, 10, 12, 162.
96. de Bock, M.; Thorstensen, E.B.; Derraik, J.G.; Henderson, H.V.; Hofman, P.L.; Cutfield, W.S. Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract. Mol. Nutr. Food Res., 2013, 57(11), 2079-2085.
97. Konno, K.; Hirayama, C.; Yasui, H.; Nakamura, M. Enzymatic activation of oleuropein: A protein crosslinker used as a chemical defense in the privet tree. Proc. Natl. Acad. Sci. USA, 1999, 96(16), 9159-9164.
98. Castelli, F.; Trombetta, D.; Tomaino, A.; Bonina, F.; Romeo, G.; Uccella, N.; Saija, A. Dipalmitoylphosphatidylcholine/linoleic acid mixed unilamellar vesicles as model membranes for studies on novel free-radical scavengers. J. Pharmacol. Toxicol. Methods, 1997, 37(3), 135-141.
99. Paiva-Martins, F.; Gordon, M.H.; Gameiro, P. Activity and location of olive oil phenolic antioxidants in liposomes. Chem. Phys. Lipids, 2003, 124(1), 23-36.
100. Caturla, N.; Perez-Fons, L.; Estepa, A.; Micol, V. Differential effects of oleuropein, a biophenol from Olea europaea, on anionic and zwiterionic phospholipid model membranes. Chem. Phys. Lipids, 2005, 137(1-2), 2-17.
101. Rodis, P.S.; Karathanos, V.T.; Mantzavinou, A. Partitioning of olive oil antioxidants between oil and water phases. J. Agric. Food Chem., 2002, 50(3), 596-601.
102. Cicerale, S.; Lucas, L.; Keast, R. Biological activities of phenolic compounds present in virgin olive oil. Int. J. Mol. Sci., 2010, 11(2), 458-479.
103. Vogel, P.; Kasper Machado, I.; Garavaglia, J.; Zani, V.T.; de Souza, D.; Morelo Dal Bosco, S. Polyphenols benefits of olive leaf (Olea europaea L) to human health. Nutr. Hosp., 2015, 31(3), 1427-1433.
104. Omar, S.H. Oleuropein in olive and its pharmacological effects. Sci. Pharm., 2010, 78(2), 133-154.
105. Vissers, M.N.; Zock, P.L.; Roodenburg, A.J.; Leenen, R.; Katan, M.B. Olive oil phenols are absorbed in humans. J. Nutr., 2002, 132(3), 409-417.
106. Sarica, S.; Toptas, S. Effects of dietary oleuropein supplementation on growth performance, serum lipid concentrations and lipid oxidation of Japanese quails. J. Anim. Physiol. Anim. Nutr., 2014, 98(6), 1176-1186.
107. Tasset, I.; Pontes, A.J.; Hinojosa, A.J.; de la Torre, R.; Tunez, I. Olive oil reduces oxidative damage in a 3-nitropropionic acidinduced Huntington's disease-like rat model. Nutr. Neurosci., 2011, 14(3), 106-111.
108. Pierno, S.; Tricarico, D.; Liantonio, A.; Mele, A.; Digennaro, C.; Rolland, J.-F.; Bianco, G.; Villanova, L.; Merendino, A.; Camerino, G.M.; De Luca, A.; Desaphy, J.-F.; Camerino, D.C. An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function. Age, 2014, 36(1), 73-88.
109. Farr, S.A.; Price, T.O.; Dominguez, L.J.; Motisi, A.; Saiano, F.; Niehoff, M.L.; Morley, J.E.; Banks, W.A.; Ercal, N.; Barbagallo, M. Extra virgin olive oil improves learning and memory in SAMP8 Mice. J. Alzheimers Dis., 2012, 28(1), 81-92.
110. Campolo, M.; Di Paola, R.; Impellizzeri, D.; Crupi, R.; Morittu, V.M.; Procopio, A.; Perri, E.; Britti, D.; Peli, A.; Esposito, E.; Cuzzocrea, S. Effects of a polyphenol present in olive oil, oleuropein aglycone, in a murine model of intestinal ischemia/reperfusion injury. J. Leukoc. Biol., 2013, 93(2), 277-287.
111. Miles, E.A.; Zoubouli, P.; Calder, P.C. Differential antiinflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures. Nutrition, 2005, 21(3), 389-394.
112. Impellizzeri, D.; Esposito, E.; Mazzon, E.; Paterniti, I.; Di Paola, R.; Bramanti, P.; Morittu, V.M.; Procopio, A.; Perri, E.; Britti, D.; Cuzzocrea, S. The effects of a polyphenol present in olive oil, oleuropein aglycone, in an experimental model of spinal cord injury in mice. Biochem. Pharmacol., 2012, 83(10), 1413-1426.
113. Pitozzi, V.; Jacomelli, M.; Catelan, D.; Servili, M.; Taticchi, A.; Biggeri, A.; Dolara, P.; Giovannelli, L. Long-term dietary extravirgin olive oil rich in polyphenols reverses age-related dysfunctions in motor coordination and contextual memory in mice: Role of oxidative stress. Rejuvenation Res., 2012, 15(6), 601-612.
114. Grossi, C.; Dami, T.E.; Rigacci, S.; Stefani, M.; Luccarini, I.; Casamenti, F. Employing Alzheimer disease animal models for translational research: Focus on dietary components. Neurodegener. Dis., 2014, 13(2-3), 131-134.
115. Sarbishegi, M.; Mehraein, F.; Soleimani, M. Antioxidant role of oleuropein on midbrain and dopaminergic neurons of substantia nigra in aged rats. Iran Biomed. J., 2014, 18(1), 16-22.
116. Rigacci, S.; Guidotti, V.; Bucciantini, M.; Parri, M.; Nediani, C.; Cerbai, E.; Stefani, M.; Berti, A. Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J. Nutr. Biochem., 2010, 21(8), 726-735.
117. Kostomoiri, M.; Fragkouli, A.; Sagnou, M.; Skaltsounis, L.A.; Pelecanou, M.; Tsilibary, E.C.; Tzinia, A.K. Oleuropein, an antioxidant polyphenol constituent of olive promotes alpha-secretase cleavage of the amyloid precursor protein (AβPP). Cell. Mol. Neurobiol., 2013, 33(1), 147-154.